Search results
Moderna wins COVID shot patent case against Pfizer-BioNTech in Europe
Reuters via AOL· 4 days agoThe company has been locked in a legal battle with Pfizer-BioNTech over their COVID shot Comirnaty...
Leaked Video of Mark Zuckerberg Discussing Vaccines Omits Context
Snopes via Yahoo News· 5 days agoWe found similar reporting from Reuters and The New York Times also putting this false rumor to bed....
NBC Securities Inc. Raises Stake in Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 5 days agoThe fund owned 1,222 shares of the company’s stock after purchasing an additional 205 shares during the period. NBC Securities Inc.’s holdings in Moderna
3 Cathie Wood Stocks to Buy Now: May 2024
InvestorPlace· 10 hours agoCathie Wood’s ARK Invest funds were unstoppable in 2020 as investors piled into disruptive innovation stocks during the low-rate lockdown environment. After peaking in early 2021, the ARK funds ...
Could Novavax Become the Next Moderna? | The Motley Fool
The Motley Fool· 5 days agoModerna fared well, dominating the vaccine market along with big pharma rival Pfizer, and bringing...
Moderna wins COVID shot patent case against Pfizer-BioNTech in Europe
Reuters· 4 days agoModerna said on Friday the European Patent Office had upheld the validity of one of the company's...
Moderna (NASDAQ:MRNA) Upgraded to Hold by Evercore ISI
ETF DAILY NEWS· 6 days agoEvercore ISI upgraded shares of Moderna (NASDAQ:MRNA – Free Report) to a hold rating in a research note released on Monday, Zacks.com reports. Canaccord Genuity Group lifted ...
The Zacks Analyst Blog Highlights Novavax, Sanofi, Fulcrum Therapeutics, Moderna and Bristol Myers
Zacks via Yahoo Finance· 5 days agoNVAX, Sanofi SNY, Fulcrum Therapeutics, Inc. FULC, Moderna, Inc. MRNA and Bristol Myers BMY. Here...
Dow Jones Dips As AI Stock Microsoft Shines; Nvidia Rallies On These Bullish Calls
Investor's Business Daily· 1 day agoNasdaq composite, however, climbed 0.7%. Micron Technology was a top performer in the composite,...
European Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech
Benzinga· 4 days agoModerna Inc MRNA has reportedly achieved a significant victory at the European Patent Office (EPO)...